Literature DB >> 1704397

Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein.

B Culmann1, E Gomard, M P Kiény, B Guy, F Dreyfus, A G Saimot, D Sereni, D Sicard, J P Lévy.   

Abstract

In order to identify the target epitopes recognized by specific CTL in the NEF protein of HIV-1, 33 peptides derived from the HIV-BRU sequence were tested with NEF-specific CTL generated from HIV-seropositive donors. Six different epitopes were identified and several points were remarkable: 1) They were all located in two regions of the central part of the NEF protein corresponding to residues 73 to 94 and 113 to 147, respectively. 2) The CTL issued from a single donor could recognize several peptides of the NEF protein. 3) Some of these peptides could be recognized in association with at least two or three different HLA class I molecules. 4) Two different overlapping epitopes were present in a relatively short sequence of 15 amino acids. These results suggest that multiple epitopes corresponding to different HLA restrictions could coexist in a relatively small region of the NEF protein. The implications of these results in vaccine strategies using synthetic peptides bearing CTL epitopes are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Authors:  P J Goulder; C Brander; K Annamalai; N Mngqundaniso; U Govender; Y Tang; S He; K E Hartman; C A O'Callaghan; G S Ogg; M A Altfeld; E S Rosenberg; H Cao; S A Kalams; M Hammond; M Bunce; S I Pelton; S A Burchett; K McIntosh; H M Coovadia; B D Walker
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity.

Authors:  Y Lu; R Friedman; N Kushner; A Doling; L Thomas; N Touzjian; M Starnbach; J Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.

Authors:  A Samri; G Haas; J Duntze; J M Bouley; V Calvez; C Katlama; B Autran
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

4.  Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection.

Authors:  G W Nelson; R Kaslow; D L Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 5.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

6.  Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue.

Authors:  Thomas Blicher; Jette Sandholm Kastrup; Lars Østergaard Pedersen; Søren Buus; Michael Gajhede
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-04

7.  Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.

Authors:  Sanjay Mendiratta; Madhu Vajpayee; Uma Malhotra; Shweta Kaushik; Lalit Dar; Kamalika Mojumdar; Neeraj Kumar Chauhan; Vishnubhatla Sreenivas
Journal:  Med Microbiol Immunol       Date:  2008-11-05       Impact factor: 3.402

8.  Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.

Authors:  Art F Y Poon; Luke C Swenson; Winnie W Y Dong; Wenjie Deng; Sergei L Kosakovsky Pond; Zabrina L Brumme; James I Mullins; Douglas D Richman; P Richard Harrigan; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2009-12-02       Impact factor: 16.240

9.  Peptide motifs of HLA-A3, -A24, and -B7 molecules as determined by pool sequencing.

Authors:  R Maier; K Falk; O Rötzschke; B Maier; V Gnau; S Stevanović; G Jung; H G Rammensee; A Meyerhans
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

10.  Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay.

Authors:  T Vogel; S Norley; B Beer; R Kurth
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.